Domain Associates & RUSNANO announce first joint investment

25 July 2012

Venture capital spurs Russian drug development – in California

Isabel Gorst, FT-Beyondbrics

When the Kremlin invited a group of US venture capitalists to Russia during the financial crisis, some of the visitors saw as much an opportunity to scout for fresh sources of capital as they did a new place to invest in.

25 July 2012

Rusnano and Domain Associates announce first joint investment

Nano werk

RusnanoMedInvest (RMI, a portfolio company of RUSNANO) and Domain Associates, the Princeton, NJ- and San Diego, CA-based venture capital firm today announced their first investment under a joint agreement reached in March. The two will jointly invest nearly $40 million in San Diego, CA-based, CoDa Therapeutics, a Domain portfolio company, along with current investors GBS Ventures (Melbourne, Australia) and BioPacificVentures (Auckland, NZ).

Coda Therapeutics raise additional $20M for series B

Private Equity Hub

CoDa Therapeutics has raised an additional $20 million from RusnanoMedInvest in a second close of its Series B financing round. This brings the total Series B Round to nearly $40 million following the first close late last year. All current investors, including Domain Associates, GBS Ventures and BioPacificVentures participated. San Diego-based CoDa is a biopharmaceutical company working to develop drug therapies for wounds that do not heal properly, including venous leg and diabetic foot ulcers.